KSHV ORF57, a protein of many faces

Viruses

Volumn 7, Issue 2, 2015, Pages 604-633

  Majerciak, Vladimir ^a   Zheng, Zhi Ming ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

KSHV; ORF57 protein; Posttranscriptional regulator; RNA processing; Viral expression

Indexed keywords

CASEIN KINASE II; CASPASE 7; DNA BINDING PROTEIN; INTERLEUKIN 6; INTRINSICALLY DISORDERED PROTEIN; MESSENGER RNA; MICRORNA 1293; NUCLEIC ACID BINDING PROTEIN; ORF50 PROTEIN; ORF57 PROTEIN; POLYADENYLATED RNA; POLYADENYLIC ACID BINDING PROTEIN; POLYCYTIDYLIC ACID BINDING PROTEIN; SRSF3 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; ORF57 PROTEIN, HUMAN HERPESVIRUS 8; VIRAL PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; DIMERIZATION; GENE; GENE EXPRESSION REGULATION; HUMAN HERPESVIRUS 8; KSHV GENE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; REVIEW; RNA SPLICING; RNA STABILITY; SPLICEOSOME; TRANSACTIVATION; TRANSCRIPTION; CHEMISTRY; GENE EXPRESSION; GENETICS; HERPES VIRUS INFECTION; HUMAN; KAPOSI SARCOMA; METABOLISM; PHOSPHORYLATION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; VIROLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

GENE EXPRESSION; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN CONFORMATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; PROTEIN STABILITY; PROTEIN TRANSPORT; RNA SPLICING; RNA STABILITY; RNA, VIRAL; SARCOMA, KAPOSI; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84922347747     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7020604     Document Type: Review

References (119)

1. Nakamura, H.; Lu, M.; Gwack, Y.; Souvlis, J.; Zeichner, S. L.; Jung, J. U. Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J. Virol. 2003, 77, 4205-4220.
2. Majerciak, V.; Ni, T.; Yang, W.; Meng, B.; Zhu, J.; Zheng, Z. M. A viral genome landscape of RNA polyadenylation from KSHV latent to lytic infection. PLoS Pathog. 2013, 9, e1003749.
3. Dresang, L. R.; Teuton, J. R.; Feng, H.; Jacobs, J. M.; Camp, D. G.; Purvine, S. O.; Gritsenko, M. A.; Li, Z.; Smith, R. D.; Sugden, B.; et al. Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: Insights on the detection and discovery of viral genes. BMC Genomics 2011, 12, 625.
4. Arias, C.; Weisburd, B.; Stern-Ginossar, N.; Mercier, A.; Madrid, A. S.; Bellare, P.; Holdorf, M.; Weissman, J. S.; Ganem, D. KSHV 2. 0: A comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features. PLoS Pathog. 2014, 10, e1003847.
5. Gradoville, L.; Gerlach, J.; Grogan, E.; Shedd, D.; Nikiforow, S.; Metroka, C.; Miller, G. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J. Virol. 2000, 74, 6207-6212.
6. Sun, R.; Lin, S. F.; Gradoville, L.; Yuan, Y.; Zhu, F.; Miller, G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. USA 1998, 95, 10866-10871.
7. Lukac, D. M.; Renne, R.; Kirshner, J. R.; Ganem, D. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 1998, 252, 304-312.
8. Majerciak, V.; Pripuzova, N.; McCoy, J. P.; Gao, S. J.; Zheng, Z. M. Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8. 1 and the production of infectious virus. J. Virol. 2007, 81, 1062-1071.
9. Han, Z.; Swaminathan, S. Kaposi's sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production. J. Virol. 2006, 80, 5251-5260.
10. Verma, D.; Li, D. J.; Krueger, B.; Renne, R.; Swaminathan, S. Identification of the Physiological Gene Targets of the Essential Lytic Replicative Kaposi's Sarcoma-Associated Herpesvirus ORF57 Protein. J. Virol. 2015, 89, 1688-1702.
11. Sandri-Goldin, R. M. The many roles of the regulatory protein ICP27 during herpes simplex virus infection. Front. Biosci. 2008, 13, 5241-5256.
12. Swaminathan, S. Post-transcriptional gene regulation by gamma herpesviruses. J. Cell. Biochem. 2005, 95, 698-711.
13. Boyne, J. R.; Colgan, K. J.; Whitehouse, A. Herpesvirus saimiri ORF57: A post-transcriptional regulatory protein. Front. Biosci. 2008, 13, 2928-2938.
14. Ote, I.; Lebrun, M.; Vandevenne, P.; Bontems, S.; Medina-Palazon, C.; Manet, E.; Piette, J.; Sadzot-Delvaux, C. Varicella-zoster virus IE4 protein interacts with SR proteins and exports mRNAs through the TAP/NXF1 pathway. PLoS One 2009, 4, e7882.
15. Majerciak, V.; Zheng, Z. M. Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing. Front. Biosci. 2009, 14, 1516-1528.
16. Majerciak, V.; Yamanegi, K.; Nie, S. H.; Zheng, Z. M. Structural and functional analyses of Kaposi sarcoma-associated herpesvirus ORF57 nuclear localization signals in living cells. J. Biol. Chem. 2006, 281, 28365-28378.
17. Schenk, E. R.; Ridgeway, M. E.; Park, M. A.; Leng, F.; Fernandez-Lima, F. Isomerization kinetics of AT hook decapeptide solution structures. Anal. Chem. 2014, 86, 1210-1214.
18. Thandapani, P.; O'Connor, T. R.; Bailey, T. L.; Richard, S. Defining the RGG/RG motif. Mol. Cell 2013, 50, 613-623.
19. Moriuchi, M.; Moriuchi, H.; Debrus, S.; Piette, J.; Cohen, J. I. The acidic amino-terminal region of varicella-zoster virus open reading frame 4 protein is required for transactivation and can functionally replace the corresponding region of herpes simplex virus ICP27. Virology 1995, 208, 376-382.
20. Majerciak, V.; Yamanegi, K.; Allemand, E.; Kruhlak, M.; Krainer, A. R.; Zheng, Z. M. Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing. J. Virol. 2008, 82, 2792-2801.
21. Li, D. J.; Verma, D.; Swaminathan, S. Binding of cellular export factor REF/Aly by Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 protein is not required for efficient KSHV lytic replication. J. Virol. 2012, 86, 9866-9874.
22. Majerciak, V.; Yamanegi, K.; Zheng, Z. M. Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59. J. Virol. 2006, 80, 11968-11981.
23. Liang, Y.; Chang, J.; Lynch, S. J.; Lukac, D. M.; Ganem, D. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 2002, 16, 1977-1989.
24. Izumiya, Y.; Izumiya, C.; Hsia, D.; Ellison, T. J.; Luciw, P. A.; Kung, H. J. NF-κB serves as a cellular sensor of Kaposi's sarcoma-associated herpesvirus latency and negatively regulates K-Rta by antagonizing the RBP-Jkappa coactivator. J. Virol. 2009, 83, 4435-4446.
25. Wen, H. J.; Minhas, V.; Wood, C. Identification and characterization of a new Kaposi's sarcoma-associated herpesvirus replication and transcription activator (RTA)-responsive element involved in RTA-mediated transactivation. J. Gen. Virol. 2009, 90, 944-953.
26. Vieira, J.; O'Hearn, P. M. Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression. Virology 2004, 325, 225-240.
27. Majerciak, V.; Deng, M.; Zheng, Z. M. Requirement of UAP56, URH49, RBM15, and OTT3 in the expression of Kaposi sarcoma-associated herpesvirus ORF57. Virology 2010, 407, 206-212.
28. Mears, W. E.; Lam, V.; Rice, S. A. Identification of nuclear and nucleolar localization signals in the herpes simplex virus regulatory protein ICP27. J. Virol. 1995, 69, 935-947.
29. Hiriart, E.; Farjot, G.; Gruffat, H.; Nguyen, M. V.; Sergeant, A.; Manet, E. A novel nuclear export signal and a REF interaction domain both promote mRNA export by the Epstein-Barr virus EB2 protein. J. Biol. Chem. 2003, 278, 335-342.
30. Nekorchuk, M.; Han, Z.; Hsieh, T. T.; Swaminathan, S. Kaposi's Sarcoma-Associated Herpesvirus ORF57 Protein Enhances mRNA Accumulation Independently of Effects on Nuclear RNA Export. J. Virol. 2007, 81, 9990-9998.
31. Majerciak, V.; Lu, M.; Li, X.; Zheng, Z. M. Attenuation of the suppressive activity of cellular splicing factor SRSF3 by Kaposi sarcoma-associated herpesvirus ORF57 protein is required for RNA splicing. RNA 2014, 20, 1747-1758.
32. Boyne, J. R.; Whitehouse, A. Nucleolar disruption impairs Kaposi's sarcoma-associated herpesvirus ORF57-mediated nuclear export of intronless viral mRNAs. FEBS Lett. 2009, 583, 3549-3556.
33. Chen, I. H.; Sciabica, K. S.; Sandri-Goldin, R. M. ICP27 interacts with the RNA export factor Aly/REF to direct herpes simplex virus type 1 intronless mRNAs to the TAP export pathway. J. Virol. 2002, 76, 12877-12889.
34. Toth, Z.; Stamminger, T. The human cytomegalovirus regulatory protein UL69 and its effect on mRNA export. Front. Biosci. 2008, 13, 2939-2949.
35. Goodwin, D. J.; Hall, K. T.; Stevenson, A. J.; Markham, A. F.; Whitehouse, A. The open reading frame 57 gene product of herpesvirus saimiri shuttles between the nucleus and cytoplasm and is involved in viral RNA nuclear export. J. Virol. 1999, 73, 10519-10524.
36. Malik, P.; Blackbourn, D. J.; Clements, J. B. The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor. J. Biol. Chem. 2004, 279, 33001-33011.
37. Massimelli, M. J.; Kang, J. G.; Majerciak, V.; Le, S. Y.; Liewehr, D. J.; Steinberg, S. M.; Zheng, Z. M. Stability of a Long Noncoding Viral RNA Depends on a 9-nt Core Element at the RNA 5' End to Interact with Viral ORF57 and Cellular PABPC1. Int. J. Biol. Sci. 2011, 7, 1145-1160.
38. Majerciak, V.; Uranishi, H.; Kruhlak, M.; Pilkington, G. R.; Massimelli, M. J.; Bear, J.; Pavlakis, G. N.; Felber, B. K.; Zheng, Z. M. Kaposi's sarcoma-associated herpesvirus ORF57 interacts with cellular RNA export cofactors RBM15 and OTT3 to promote expression of viral ORF59. J. Virol. 2011, 85, 1528-1540.
39. Sahin, B. B.; Patel, D.; Conrad, N. K. Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways. PLoS Pathog. 2010, 6, e1000799.
40. Pilkington, G. R.; Majerciak, V.; Bear, J.; Uranishi, H.; Zheng, Z. M.; Felber, B. K. Kaposi's Sarcoma-Associated Herpesvirus ORF57 Is Not a Bona Fide Export Factor. J. Virol. 2012, 86, 13089-13094.
41. Tunnicliffe, R. B.; Hautbergue, G. M.; Kalra, P.; Jackson, B. R.; Whitehouse, A.; Wilson, S. A.; Golovanov, A. P. Structural basis for the recognition of cellular mRNA export factor REF by herpes viral proteins HSV-1 ICP27 and HVS ORF57. PLoS Pathog. 2011, 7, e1001244.
42. Strasser, K.; Masuda, S.; Mason, P.; Pfannstiel, J.; Oppizzi, M.; Rodriguez-Navarro, S.; Rondon, A. G.; Aguilera, A.; Struhl, K.; Reed, R.; et al. TREX is a conserved complex coupling transcription with messenger RNA export. Nature 2002, 417, 304-308.
43. Rodrigues, J. P.; Rode, M.; Gatfield, D.; Blencowe, B. J.; Carmo-Fonseca, M.; Izaurralde, E. REF proteins mediate the export of spliced and unspliced mRNAs from the nucleus. Proc. Natl. Acad. Sci. USA 2001, 98, 1030-1035.
44. Nojima, T.; Hirose, T.; Kimura, H.; Hagiwara, M. The interaction between cap-binding complex and RNA export factor is required for intronless mRNA export. J. Biol. Chem. 2007, 282, 15645-15651.
45. Boyne, J. R.; Colgan, K. J.; Whitehouse, A. Recruitment of the complete hTREX complex is required for Kaposi's sarcoma-associated herpesvirus intronless mRNA nuclear export and virus replication. PLoS Pathog. 2008, 4, e1000194.
46. Longman, D.; Johnstone, I. L.; Caceres, J. F. The Ref/Aly proteins are dispensable for mRNA export and development in Caenorhabditis elegans. RNA 2003, 9, 881-891.
47. Gatfield, D.; Izaurralde, E. REF1/Aly and the additional exon junction complex proteins are dispensable for nuclear mRNA export. J. Cell. Biol. 2002, 159, 579-588.
48. Johnson, L. A.; Li, L.; Sandri-Goldin, R. M. The cellular RNA export receptor TAP/NXF1 is required for ICP27-mediated export of herpes simplex virus 1 RNA, but the TREX complex adaptor protein Aly/REF appears to be dispensable. J. Virol. 2009, 83, 6335-6346.
49. Hautbergue, G. M.; Hung, M. L.; Walsh, M. J.; Snijders, A. P.; Chang, C. T.; Jones, R.; Ponting, C. P.; Dickman, M. J.; Wilson, S. A. UIF, a New mRNA export adaptor that works together with REF/ALY, requires FACT for recruitment to mRNA. Curr. Biol. 2009, 19, 1918-1924.
50. Jackson, B. R.; Boyne, J. R.; Noerenberg, M.; Taylor, A.; Hautbergue, G. M.; Walsh, M. J.; Wheat, R.; Blackbourn, D. J.; Wilson, S. A.; Whitehouse, A. An interaction between KSHV ORF57 and UIF provides mRNA-adaptor redundancy in herpesvirus intronless mRNA export. PLoS Pathog. 2011, 7, e1002138.
51. Stubbs, S. H.; Hunter, O. V.; Hoover, A.; Conrad, N. K. Viral factors reveal a role for REF/Aly in nuclear RNA stability. Mol. Cell. Biol. 2012, 32, 1260-1270.
52. Rossetto, C. C.; Pari, G. KSHV PAN RNA Associates with Demethylases UTX and JMJD3 to Activate Lytic Replication through a Physical Interaction with the Virus Genome. PLoS Pathog. 2012, 8, e1002680.
53. Rossetto, C. C.; Pari, G. S. KSHV noncoding PAN RNA interacts with virus and cellular-encoded proteins and suppresses expression of genes involved in immune modulation. J. Virol. 2011, 85, 13290-13297.
54. Campbell, M.; Kim, K. Y.; Chang, P. C.; Huerta, S.; Shevchenko, B.; Wang, D. H.; Izumiya, C.; Kung, H. J.; Izumiya, Y. A lytic viral long noncoding RNA modulates the function of a latent protein. J. Virol. 2014, 88, 1843-1848.
55. Kirshner, J. R.; Lukac, D. M.; Chang, J.; Ganem, D. Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J. Virol. 2000, 74, 3586-3597.
56. Massimelli, M. J.; Majerciak, V.; Kruhlak, M.; Zheng, Z. M. Interplay between polyadenylate-binding protein 1 and Kaposi's sarcoma-associated herpesvirus ORF57 in accumulation of polyadenylated nuclear RNA, a viral long noncoding RNA. J. Virol. 2013, 87, 243-256.
57. Sei, E.; Conrad, N. K. Delineation of a core RNA element required for Kaposi's sarcoma-associated herpesvirus ORF57 binding and activity. Virology 2011, 419, 107-116.
58. Kang, J. G.; Pripuzova, N.; Majerciak, V.; Kruhlak, M.; Le, S. Y.; Zheng, Z. M. Kaposi's Sarcoma-Associated Herpesvirus ORF57 Promotes Escape of Viral and Human Interleukin-6 from MicroRNA-Mediated Suppression. J. Virol. 2011, 85, 2620-2630.
59. Schwanhausser, B.; Busse, D.; Li, N.; Dittmar, G.; Schuchhardt, J.; Wolf, J.; Chen, W.; Selbach, M. Global quantification of mammalian gene expression control. Nature 2011, 473, 337-342.
60. Rabani, M.; Levin, J. Z.; Fan, L.; Adiconis, X.; Raychowdhury, R.; Garber, M.; Gnirke, A.; Nusbaum, C.; Hacohen, N.; Friedman, N.; et al. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat. Biotechnol. 2011, 29, 436-442.
61. Tani, H.; Mizutani, R.; Salam, K. A.; Tano, K.; Ijiri, K.; Wakamatsu, A.; Isogai, T.; Suzuki, Y.; Akimitsu, N. Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals. Genome Res. 2012, 22, 947-956.
62. Conrad, N. K.; Steitz, J. A. A Kaposi's sarcoma virus RNA element that increases the nuclear abundance of intronless transcripts. EMBO J. 2005, 24, 1831-1841.
63. Conrad, N. K.; Shu, M. D.; Uyhazi, K. E.; Steitz, J. A. Mutational analysis of a viral RNA element that counteracts rapid RNA decay by interaction with the polyadenylate tail. Proc. Natl. Acad. Sci. USA 2007, 104, 10412-10417.
64. Lee, Y. J.; Glaunsinger, B. A. Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction. PLoS Biol. 2009, 7, e1000107.
65. Borah, S.; Darricarrere, N.; Darnell, A.; Myoung, J.; Steitz, J. A. A Viral Nuclear Noncoding RNA Binds Re-localized Poly(A) Binding Protein and Is Required for Late KSHV Gene Expression. PLoS Pathog. 2011, 7, e1002300.
66. Massimelli, M. J.; Majerciak, V.; Kang, J.-G.; Liewehr, D. J.; Steinberg, S. M.; Zheng, Z. M. Multiple regions of Kaposi sarcoma-associated herpesvirus ORF59 RNA are required for its expression mediated by viral ORF57 and cellular RBM15. Viruses 2015, 7, 496-510.
67. Wu, X.; Brewer, G. The regulation of mRNA stability in mammalian cells: 2. 0. Gene 2012, 500, 10-21.
68. Zheng, Z. M. Split genes and their expression in Kaposi's sarcoma-associated herpesvirus. Rev. Med. Virol. 2003, 13, 173-184.
69. Jia, R.; Li, C.; McCoy, J. P.; Deng, C. X.; Zheng, Z. M. SRp20 is a proto-oncogene critical for cell proliferation and tumor induction and maintenance. Int. J. Biol. Sci. 2010, 6, 806-826.
70. Verma, D.; Swaminathan, S. Epstein-Barr virus SM protein functions as an alternative splicing factor. J. Virol. 2008, 82, 7180-7188.
71. Verma, D.; Bais, S.; Gaillard, M.; Swaminathan, S. Epstein-Barr Virus SM protein utilizes cellular splicing factor SRp20 to mediate alternative splicing. J. Virol. 2010, 84, 11781-11789.
72. Sciabica, K. S.; Dai, Q. J.; Sandri-Goldin, R. M. ICP27 interacts with SRPK1 to mediate HSV splicing inhibition by altering SR protein phosphorylation. EMBO J. 2003, 22, 1608-1619.
73. Escudero-Paunetto, L.; Li, L.; Hernandez, F. P.; Sandri-Goldin, R. M. SR proteins SRp20 and 9G8 contribute to efficient export of herpes simplex virus 1 mRNAs. Virology 2010, 401, 155-164.
74. Nishimura, K.; Ueda, K.; Guwanan, E.; Sakakibara, S.; Do, E.; Osaki, E.; Yada, K.; Okuno, T.; Yamanishi, K. A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRES. Virology 2004, 325, 364-378.
75. Boyne, J. R.; Jackson, B. R.; Taylor, A.; Macnab, S. A.; Whitehouse, A. Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs. EMBO J. 2010, 29, 1851-1864.
76. Forler, D.; Kocher, T.; Rode, M.; Gentzel, M.; Izaurralde, E.; Wilm, M. An efficient protein complex purification method for functional proteomics in higher eukaryotes. Nat. Biotechnol. 2003, 21, 89-92.
77. Diem, M. D.; Chan, C. C.; Younis, I.; Dreyfuss, G. PYM binds the cytoplasmic exon-junction complex and ribosomes to enhance translation of spliced mRNAs. Nat. Struct. Mol. Biol. 2007, 14, 1173-1179.
78. Gehring, N. H.; Lamprinaki, S.; Kulozik, A. E.; Hentze, M. W. Disassembly of exon junction complexes by PYM. Cell 2009, 137, 536-548.
79. Kang, J. G.; Majerciak, V.; Uldrick, T. S.; Wang, X.; Kruhlak, M.; Yarchoan, R.; Zheng, Z. M. Kaposi's sarcoma-associated herpesviral IL-6 and human IL-6 open reading frames contain miRNA binding sites and are subject to cellular miRNA regulation. J. Pathol. 2011, 225, 378-389.
80. Chatterjee, M.; Osborne, J.; Bestetti, G.; Chang, Y.; Moore, P. S. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 2002, 298, 1432-1435.
81. Jones, K. D.; Aoki, Y.; Chang, Y.; Moore, P. S.; Yarchoan, R.; Tosato, G. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 1999, 94, 2871-2879.
82. Osborne, J.; Moore, P. S.; Chang, Y. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum. Immunol. 1999, 60, 921-927.
83. Malik, P.; Blackbourn, D. J.; Cheng, M. F.; Hayward, G. S.; Clements, J. B. Functional co-operation between the Kaposi's sarcoma-associated herpesvirus ORF57 and ORF50 regulatory proteins. J. Gen. Virol. 2004, 85, 2155-2166.
84. Palmeri, D.; Spadavecchia, S.; Carroll, K. D.; Lukac, D. M. Promoter-and cell-specific transcriptional transactivation by the Kaposi's sarcoma-associated herpesvirus ORF57/Mta protein. J. Virol. 2007, 81, 13299-13314.
85. Hunter, O. V.; Sei, E.; Richardson, R. B.; Conrad, N. K. Chromatin immunoprecipitation and microarray analysis suggest functional cooperation between Kaposi's Sarcoma-associated herpesvirus ORF57 and K-bZIP. J. Virol. 2013, 87, 4005-4016.
86. Uetz, P.; Dong, Y. A.; Zeretzke, C.; Atzler, C.; Baiker, A.; Berger, B.; Rajagopala, S. V.; Roupelieva, M.; Rose, D.; Fossum, E.; et al. Herpesviral protein networks and their interaction with the human proteome. Science 2006, 311, 239-242.
87. Sandri-Goldin, R. M. The many roles of the highly interactive HSV protein ICP27, a key regulator of infection. Future Microbiol. 2011, 6, 1261-1277.
88. Dai-Ju, J. Q.; Li, L.; Johnson, L. A.; Sandri-Goldin, R. M. ICP27 interacts with the C-terminal domain of RNA polymerase II and facilitates its recruitment to herpes simplex virus 1 transcription sites, where it undergoes proteasomal degradation during infection. J. Virol. 2006, 80, 3567-3581.
89. Jackson, B. R.; Noerenberg, M.; Whitehouse, A. A novel mechanism inducing genome instability in Kaposi's sarcoma-associated herpesvirus infected cells. PLoS Pathog. 2014, 10, e1004098.
90. Majerciak, V.; Pripuzova, N.; Chan, C.; Temkin, N.; Specht, S. I.; Zheng, Z. M. Stability of structured Kaposi sarcoma-associated herpesvirus ORF57 protein is regulated by protein phosphorylation and homodimerization. J. Virol. 2015, doi: 10. 1128/JVI. 03721-14.
91. Uversky, V. N.; Gillespie, J. R.; Fink, A. L. Why are "natively unfolded" proteins unstructured under physiologic conditions? Proteins 2000, 41, 415-427.
92. Lischka, P.; Thomas, M.; Toth, Z.; Mueller, R.; Stamminger, T. Multimerization of human cytomegalovirus regulatory protein UL69 via a domain that is conserved within its herpesvirus homologues. J. Gen. Virol. 2007, 88, 405-410.
93. Hernandez, F. P.; Sandri-Goldin, R. M. Herpes simplex virus 1 regulatory protein ICP27 undergoes a head-to-tail intramolecular interaction. J. Virol. 2010, 84, 4124-4135.
94. Taylor, A.; Jackson, B. R.; Noerenberg, M.; Hughes, D. J.; Boyne, J. R.; Verow, M.; Harris, M.; Whitehouse, A. Mutation of a C-terminal motif affects Kaposi's sarcoma-associated herpesvirus ORF57 RNA binding, nuclear trafficking, and multimerization. J. Virol. 2011, 85, 7881-7891.
95. Jones, D. T. Protein secondary structure prediction based on position-specific scoring matrices. J. Mol. Biol. 1999, 292, 195-202.
96. Dosztanyi, Z.; Meszaros, B.; Simon, I. ANCHOR: Web server for predicting protein binding regions in disordered proteins. Bioinformatics 2009, 25, 2745-2746.
97. Iakoucheva, L. M.; Radivojac, P.; Brown, C. J.; O'Connor, T. R.; Sikes, J. G.; Obradovic, Z.; Dunker, A. K. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 2004, 32, 1037-1049.
98. Zhi, Y.; Sandri-Goldin, R. M. Analysis of the phosphorylation sites of herpes simplex virus type 1 regulatory protein ICP27. J. Virol. 1999, 73, 3246-3257.
99. Medina-Palazon, C.; Gruffat, H.; Mure, F.; Filhol, O.; Vingtdeux-Didier, V.; Drobecq, H.; Cochet, C.; Sergeant, N.; Sergeant, A.; Manet, E. Protein kinase CK2 phosphorylation of EB2 regulates its function in the production of Epstein-Barr virus infectious viral particles. J. Virol. 2007, 81, 11850-11860.
100. Van der Lee, R.; Buljan, M.; Lang, B.; Weatheritt, R. J.; Daughdrill, G. W.; Dunker, A. K.; Fuxreiter, M.; Gough, J.; Gsponer, J.; Jones, D. T.; et al. Classification of intrinsically disordered regions and proteins. Chem. Rev. 2014, 114, 6589-6631.
101. Dunker, A. K.; Silman, I.; Uversky, V. N.; Sussman, J. L. Function and structure of inherently disordered proteins. Curr. Opin. Struct. Biol. 2008, 18, 756-764.
102. Goh, G. K.; Dunker, A. K.; Uversky, V. N. Protein intrinsic disorder toolbox for comparative analysis of viral proteins. BMC Genomics 2008, 9 (Suppl. 2), S4.
103. Uversky, V. N.; Roman, A.; Oldfield, C. J.; Dunker, A. K. Protein intrinsic disorder and human papillomaviruses: Increased amount of disorder in E6 and E7 oncoproteins from high risk HPVs. J. Proteome Res. 2006, 5, 1829-1842.
104. Xue, B.; Blocquel, D.; Habchi, J.; Uversky, A. V.; Kurgan, L.; Uversky, V. N.; Longhi, S. Structural disorder in viral proteins. Chem. Rev. 2014, 114, 6880-6911.
105. Malik, P.; Clements, J. B. Protein kinase CK2 phosphorylation regulates the interaction of Kaposi's sarcoma-associated herpesvirus regulatory protein ORF57 with its multifunctional partner hnRNP K. Nucleic Acids Res. 2004, 32, 5553-5569.
106. Malik, P.; Tabarraei, A.; Kehlenbach, R. H.; Korfali, N.; Iwasawa, R.; Graham, S. V.; Schirmer, E. C. Herpes simplex virus ICP27 protein directly interacts with the nuclear pore complex through Nup62, inhibiting host nucleocytoplasmic transport pathways. J. Biol. Chem. 2012, 287, 12277-12292.
107. Johnson, L. A.; Sandri-Goldin, R. M. Efficient nuclear export of herpes simplex virus 1 transcripts requires both RNA binding by ICP27 and ICP27 interaction with TAP/NXF1. J. Virol. 2009, 83, 1184-1192.
108. Toth, Z.; Lischka, P.; Stamminger, T. RNA-binding of the human cytomegalovirus transactivator protein UL69, mediated by arginine-rich motifs, is not required for nuclear export of unspliced RNA. Nucleic Acids Res. 2006, 34, 1237-1249.
109. Sergeant, A.; Gruffat, H.; Manet, E. The Epstein-Barr virus (EBV) protein EB is an mRNA export factor essential for virus production. Front. Biosci. 2008, 13, 3798-3813.
110. Tunnicliffe, R. B.; Hautbergue, G. M.; Wilson, S. A.; Kalra, P.; Golovanov, A. P. Competitive and cooperative interactions mediate RNA transfer from herpesvirus saimiri ORF57 to the mammalian export adaptor ALYREF. PLoS Pathog. 2014, 10, e1003907.
111. Calnan, B. J.; Biancalana, S.; Hudson, D.; Frankel, A. D. Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. Genes Dev. 1991, 5, 201-210.
112. Lazinski, D.; Grzadzielska, E.; Das, A. Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich motif. Cell 1989, 59, 207-218.
113. Bayer, T. S.; Booth, L. N.; Knudsen, S. M.; Ellington, A. D. Arginine-rich motifs present multiple interfaces for specific binding by RNA. RNA 2005, 11, 1848-1857.
114. Ruvolo, V.; Sun, L.; Howard, K.; Sung, S.; Delecluse, H. J.; Hammerschmidt, W.; Swaminathan, S. Functional analysis of Epstein-Barr virus SM protein: Identification of amino acids essential for structure, transactivation, splicing inhibition, and virion production. J. Virol. 2004, 78, 340-352.
115. Zhi, Y.; Sciabica, K. S.; Sandri-Goldin, R. M. Self-interaction of the herpes simplex virus type 1 regulatory protein ICP27. Virology 1999, 257, 341-351.
116. Majerciak, V.; Kruhlak, M.; Dagur, P. K.; McCoy, J. P., Jr.; Zheng, Z. M. Caspase-7 cleavage of Kaposi sarcoma-associated herpesvirus ORF57 confers a cellular function against viral lytic gene expression. J. Biol. Chem. 2010, 285, 11297-11307.
117. Desagher, S.; Osen-Sand, A.; Montessuit, S.; Magnenat, E.; Vilbois, F.; Hochmann, A.; Journot, L.; Antonsson, B.; Martinou, J. C. Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol. Cell 2001, 8, 601-611.
118. Tozser, J.; Bagossi, P.; Zahuczky, G.; Specht, S. I.; Majerova, E.; Copeland, T. D. Effect of caspase cleavage-site phosphorylation on proteolysis. Biochem. J. 2003, 372, 137-143.
119. Koffa, M. D.; Kean, J.; Zachos, G.; Rice, S. A.; Clements, J. B. CK2 protein kinase is stimulated and redistributed by functional herpes simplex virus ICP27 protein. J. Virol. 2003, 77, 4315-4325.